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Abstract In rat pancreatic zymogen granules (ZG), a K

selective conductance which can be blocked by ATP has been
characterized. Here we show that this pathway can be
specifically blocked by glibenclamide. Using a rapid filtration
assay, we also found specific binding of [
3
H]glibenclamide to a
low-affinity site (K
d
5.6þ 1.1 WM) in rat pancreatic zymogen
granule membranes (ZGM). In photoaffinity labeling experi-
ments with [
3
H]glibenclamide, a 65þ 1.5 kDa polypeptide was
specifically labeled. Previously, aV65 kDa mdr1 gene product
has been demonstrated to be involved in the regulation of the K

selective conductance of ZG. We conclude that this protein may
be a subunit of, or associated with, a ZG K
ATP
channel.
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1. Introduction
In zymogen granules (ZG) of the exocrine pancreas, a K

conductance has been described which may be involved in
enzyme and £uid secretion induced by secretagogues [1]. The
K

conductance can be blocked by ATP, non-hydrolysable
ATP analogues and glibenclamide and activated by diazoxide
in the presence of MgATP. These are characteristic features of
ATP-sensitive K

(K
ATP
) channels, that have ¢rst been found
in the heart and in pancreatic L-cells [2,3]. The K
ATP
channels
of the pancreatic L-cell and the heart have been shown to be
composed of two di¡erent subunits [4]: the channel pore is
formed by Kir 6.2, a member of the inwardly rectifying po-
tassium (Kir) channel family, while the other subunit repre-
sents the sulfonylurea receptor (SUR) [5,6]. The SUR is a
member of the ATP binding cassette (ABC) transporter super-
family [7], which also includes the multidrug resistance (mdr)
P-glycoprotein (for review, see [8]) and the cystic ¢brosis
transmembrane conductance regulator (CFTR) [9].
Previously, we have shown that the K

conductance of ZG
is composed of a K

selective and a non-selective cation con-
ductance [10]. In this study, we show that the K

selective
but not the non-selective cation conductance can be speci¢-
cally blocked by glibenclamide. In addition, we describe the
characterization of a low-a¤nity binding site for
[
3
H]glibenclamide in rat pancreatic zymogen granule mem-
branes (ZGM) by a rapid ¢ltration assay and its putative
localization on a 65 kDa protein by photoa¤nity labeling.
This corresponds to the molecular weight of a protein cross-
reacting with mdr1 antibodies which is involved in the regu-
lation of the K

selective cation conductance in pancreatic
ZG [10,11]. The data suggest that the 65 kDa protein photo-
labeled by glibenclamide is a subunit of the K

channel
underlying the ATP- and glibenclamide-blockable K

con-
ductance present in ZGM.
2. Materials and methods
2.1. Materials
[
3
H]Glibenclamide (V50 Ci/mmol) was obtained from Dupont
NEN (Bad Homburg, Germany). Unlabeled glibenclamide, gliqui-
done, gliclacide, glipizide and glisoxepide were a kind gift of Dr. H.
Englert (Hoechst AG, Frankfurt/Main, Germany). Soluene-350 and
Ultima Gold were from Packard (Groningen, The Netherlands). Pe-
fabloc SC was from Boehringer (Mannheim, Germany). Carbonyl-
cyanide m-chlorophenylhydrazone (CCCP), adenosine triphosphate
(ATP), adenosine diphosphate (ADP), adenosine tetraphosphate
(AttP), adenosine 5P-(L,Q-methylene)triphosphate (AMP-PCP), guano-
sine triphosphate (GTP) and bovine serum albumin were from Sigma
(Deisenhofen, Germany). Percoll was from Pharmacia (Uppsala, Swe-
den). All other chemicals were of analytical grade.
2.2. Isolation of ZG and puri¢cation of ZG membranes
ZG from rat exocrine pancreas were isolated as described earlier
[12,13]. Brie£y, pancreatic tissue from male Wistar rats (180^250 g;
Charles River Wiga GmbH, Sulzfeld, Germany) was homogenized by
nitrogen pressure cavitation (500 psi), and ZG were isolated by cen-
trifugation of the homogenate on a self-forming continuous Percoll-
Gradient (40% Percoll v/v at 20 000Ug for 20 min). ZG form a dis-
tinct dense whitish band on the bottom of the gradient. For separa-
tion from minor mitochondrial contaminations ZG were washed in an
isotonic bu¡er containing 50 mM succinate followed by centrifugation
at 1000Ug for 20 min [14].
For puri¢cation of ZGM the protocol described by The
è
venod et al.
[13] was used with minor modi¢cations. ZG were diluted about 20-
fold in a hypotonic `lysis bu¡er' containing 10 mM HEPES, 0.1 mM
MgSO
4
, adjusted to pH 7.0 with Tris, and a protease inhibitor `cock-
tail' (10 WM leupeptin, 100 Wg/ml trypsin inhibitor, 2 mM benzami-
dine, 0.2 mM Pefabloc SC). During incubation on ice the suspension
cleared within 45 min and was then centrifuged for 1 h at 100 000Ug.
The pellet was resuspended in `lysis bu¡er' and centrifugation was
repeated. The protein concentration of the ¢nal pellet containing
the ZGM was determined according to Bradford [15] using bovine
serum albumin as a standard. Membranes were stored at 370³C until
use.
2.3. Measurement of cation conductance
Cation conductance of pancreatic ZG was assayed according to a
previously reported protocol for the quantitative evaluation of macro-
scopic ion £uxes through endogenous conductance pathways of ZG
membranes [1]. This assay relies on the measurement of osmotic lysis
of ZG resuspended in bu¡ered isotonic salt solutions, which is in-
duced by addition of electrogenic ionophores allowing for membrane
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permeation of counterions. Granule lysis causes a decrease in absorb-
ance of the suspension which is measured at a wavelength of 540 nm
in a Beckman DU-64 spectrophotometer at 37³C.
ZG were suspended in 150 mM K

or Na

acetate solution con-
taining 1 mM EDTA and bu¡ered with 50 mM imidazole (pH 7.0,
adjusted with acetic acid). Since the intragranule pH is about 6.5, and
the membrane permeability for protons is low [1], an inside-to-outside
directed H

concentration gradient of V0.5 pH units is generated
across the granule membrane. Addition of 16 WM of the electrogenic
protonophore CCCP, which maximally permeabilizes the granule
membrane to H

, converts the H

concentration gradient into an
inside negative H

di¡usion potential which, in turn, energizes cation
in£ux through endogenous cation permeabilities. Anion in£ux occurs
through the uncharged molecule acetic acid, which permeates through
the lipid membrane by non-ionic di¡usion and dissociates to provide
the intragranule space continuously with protons for protonation of
imidazole as well as for proton e¥ux from the acidic interior [1].
Under these conditions cation in£ux through endogenous cation per-
meabilities becomes rate-limiting.
Since bulk salt in£ux into the intragranule space and the resulting
granule lysis are limited by the £ux of ions through the endogenous
conductance pathway, but not by the £ux of counterions through the
shunt pathway, the slope of the decrease in absorbance with time will
represent an estimate of the rate of ions transported through the
endogenous conductance pathway. Lysis rates were expressed as in-
verse half-times of lysis, which were considered proportional to the
rate constant of lysis. Half-time of granule lysis was estimated from
the slope of the decrease in absorbance with time between addition of
ionophore and either experimental half-time or the entire observation
period if the half-time was not reached. The slope of the absorbance
change with time was estimated by linear regression of the digitized
data.
2.4. Rapid ¢ltration assay
A rapid ¢ltration assay for measurement of [
3
H]glibenclamide equi-
librium binding was performed essentially as described by Gaines et
al. [16], with minor modi¢cations. Brie£y, 100 Wg of ZGM were in-
cubated with 10 nM [
3
H]glibenclamide in assay bu¡er (50 mM Tris/
HCl, 0.1 mM Pefabloc SC, pH 7.4; 250 Wl assay volume) in the
presence or absence of unlabeled drugs for 1 h at room temperature
(varying incubation times between 15 min and 2 h showed that equil-
ibration was complete after 1 h). Stock solutions of unlabeled drugs
were prepared in dimethylsulfoxide (DMSO), the ¢nal concentration
of which in the assay was 1% (at this concentration DMSO did not
a¡ect equilibrium binding). All determinations were performed in du-
plicate. Incubation was terminated by addition of 3.5 ml of ice-cold
assay bu¡er followed by immediate ¢ltration over Whatman GF/F
glass ¢ber ¢lters under reduced pressure. Filters were washed 3 times
with 3.5 ml of bu¡er. Filter-bound radioactivity was determined by
liquid scintillation counting.
IC
50
values were obtained from competition experiments by ¢tting
of the data to the general dose^response equation for a single binding
component [17]. According to the Cheng-Pruso¡ equation, IC
50
val-
ues were equated with K
i
values or, in the case of homologous com-
petition, with K
d
values [18].
2.5. Photoa¤nity labeling
Photoa¤nity labeling was performed according to Kramer et al.
[19]. 100 Wg of ZGM were incubated with 100 nM [
3
H]glibenclamide
in assay bu¡er (as described under `rapid ¢ltration assay') in a total
volume of 50 Wl. Non-speci¢c binding was determined in the presence
of 20 WM unlabeled glibenclamide. After equilibration for 1 h at room
temperature the samples were transferred to microtiter plates and
irradiated with ultraviolet light (254 nm wavelength) at a distance
of 5 cm for 8 min on ice (V0.8 J/cm
2
). For separation of unbound
radioactivity samples were then diluted 10-fold with bu¡er containing
10 mM Tris/HCl, 4 mM EDTA, 4 mM iodoacetamide, 0.1 mM Pefa-
bloc SC, pH 7.4, and centrifuged for 30 min at 48 000Ug. The mem-
brane pellets were resuspended in sample bu¡er containing 2% SDS
and 5% 2-mercaptoethanol (pH 6.8) and separated by SDS-PAGE on
7.5% acrylamide minigels [20]. The lanes were cut into 3 mm pieces
which were placed in scintillation vials. After addition of 0.4 ml Sol-
uene-350 for elution of radioactivity from the gel pieces and 8 ml
Ultima Gold and incubation overnight, radioactivity was measured
in a liquid scintillation counter.
2.6. Statistics
All experiments were performed at least three-fold; the exact num-
ber of experiments is given with the respective results. Variability of
the data is expressed as meansþS.D. or meansþS.E.M. Statistical
analysis of the granule lysis data was done with the Statgraphics
program using paired Student's t-test. Non-linear regression analysis
of the binding data according to the least-squares method was done
with the Sigma-Plot program (Jandel Scienti¢c Software, San Rafael,
USA).
3. Results
3.1. Measurement of cation conductances
The presence of an ATP-sensitive, K

-selective and a non-
selective cation pathway in ZG has been described previously
[10]. The K

-selective conductance is inhibited by ATP and its
non-hydrolysable analogues [10]. About 60% of the granule
lysis in isotonic K

bu¡er is mediated by the K

-selective
conductance, whereas the remaining 40% are mediated by
the non-selective cation conductance [10].
To further characterize the K

-selective conductance in
ZG, we compared the inhibitory e¡ect of glibenclamide on
the cation conductance of granules incubated in K

or Na

FEBS 18859 12-9-97
Fig. 1. E¡ect of glibenclamide on K

and Na

conductance of zym-
ogen granules (ZG). ZG were incubated in isotonic K

acetate (A)
or Na

acetate (B) imidazole bu¡er plus or minus the indicated
concentrations of glibenclamide in the cuvette at 37³C for 5 min.
The absorbance of the ZG suspension was followed at 540 nm. K

conductance (A) and Na

conductance (B) were measured after ad-
dition of the protonophore, CCCP (at the arrow).
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acetate bu¡er. The e¡ect of di¡erent concentrations of gliben-
clamide (10 nM^100 WM) on ZG lysis in K

and Na

acetate
after addition of CCCP is shown in Fig. 1A,B. Glibenclamide
inhibits K
ATP
channels by binding to a high-a¤nity SUR [5].
An e¡ect of glibenclamide on non-selective cation channels is
not described. Dose-dependent inhibition of CCCP-induced
ZG lysis with glibenclamide was observed in K

acetate
(Fig. 1A) but not in Na

acetate (Fig. 1B). Maximal inhib-
ition of ZG lysis in K

acetate occurred with 10 WM gliben-
clamide; the control lysis rate of 30.3 þ 8.9Wh
31
was reduced
by 71.4þ 5.4% to 8.2þ 1.8Wh
31
(meansþ S.D., n=9,
P6 0.0001, paired Student's t-test). With Na

acetate, control
lysis rate of ZG was 8.1þ 0.6Wh
31
, addition of 10 nM^100 WM
glibenclamide reduced ZG lysis independently of the concen-
tration of glibenclamide tested by about 40%. At the maximal
concentration of glibenclamide tested (100 WM) lysis was re-
duced by 42.3 þ 7.2% to 4.7þ 0.4Wh
31
(meansþSD, n=3,
P6 0.02 paired Student's t-test). This indicates that glibencla-
mide speci¢cally inhibits the K

-selective conductance as
compared to the Na

-permeable non-selective cation conduct-
ance in ZG.
3.2. Rapid ¢ltration assay
By competition experiments with unlabeled glibenclamide a
speci¢c component of [
3
H]glibenclamide binding to ZGM was
detected which accounted for 43þ 1.6% of total binding. A
further characterization of the speci¢c binding component was
done by competition with increasing doses of unlabeled gli-
benclamide. A K
d
of 5.6 þ 1.1 WM (meansþ S.E.M.; n=8) for
glibenclamide binding was determined from the inhibition
curves (Fig. 2). The Hill plot yielded a slope factor of
0.83 þ 0.1, indicating a lack of cooperativity in binding (Fig.
2, inset). A B
max
of 11þ 2.4 pmol/mg protein was calculated
from the binding amplitude, taking into account the degree of
saturation at the given label concentration [21]. Scatchard
analysis of saturation binding data calculated from the inhib-
ition curves according to Boer et al. [22] con¢rmed the exist-
ence of a single class of low-a¤nity binding sites (data not
shown).
For pharmacological characterization of the glibenclamide
binding site in ZGM, sulfonylurea derivatives known to bind
to SUR, K
ATP
channel activators and substances that inhibit
the K

conductance in ZG [1] were tested for their ability to
displace [
3
H]glibenclamide from ZGM. Of the second-
generation sulfonylureas tested, gliquidone inhibited
[
3
H]glibenclamide binding in a similar concentration range
to that of glibenclamide with an IC
50
ofV2 WM. The potency
of binding inhibition of the other second-generation sulfo-
nylureas was lower, and the overall sequence gliquidones gli-
pizides glisoxepides gliclacide was determined (Table 1).
The ¢rst-generation sulfonylurea, tolbutamide, did not inhibit
[
3
H]glibenclamide binding at a concentration of 100 WM,
which is in agreement with its lack of inhibition of ZG K

conductance [1].
Nucleotides also inhibited [
3
H]glibenclamide binding to
ZGM (Table 1). ATP and the non-hydrolysable ATP ana-
logues, AMP-PCP and AttP, were the most e¡ective nucleo-
tides tested. The inhibition by ATP was independent of Mg
2
(data not shown), suggesting that binding inhibition of
[
3
H]glibenclamide by ATP does not involve a phosphoryla-
tion-mediated process.
The K

channel blockers, quinine and quinidine, which
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Fig. 2. Binding inhibition of [
3
H]glibenclamide by glibenclamide in
rat pancreatic ZGM and Hill plot of the data (inset). Non-speci¢c
binding was de¢ned at 200 WM glibenclamide. 100% speci¢c
[
3
H]glibenclamide binding (total binding^non-speci¢c binding) corre-
sponded to 169þ 14 dpm (meansþS.E.M.). The curves show pooled
data from 8 experiments ( þ S.E.M.).
Table 1
Inhibition of [
3
H]glibenclamide binding to ZGM by sulfonylureas, nucleotides, K
ATP
channel openers and blockers of ZG K

conductance
Compound Concentration (M) Percent of binding inhibition
(meansþS.E.M.)
n
Gliquidone 10
34
102þ 6 3
Glipizide 10
34
65þ 9 4
Glisoxepide 10
34
49þ 2 4
Gliclacide 10
34
35þ 10 4
Tolbutamide 10
34
1þ 14 3
ATP 5U10
34
62þ 8 6
AMP-PCP 5U10
34
61þ 11 5
AttP 5U10
34
64þ 9 4
ADP 5U10
34
51þ 5 3
GTP 5U10
34
54þ 8 3
Minoxidil sulfate 10
34
4þ 17 5
Diazoxide 10
34
5þ 9 5
Quinidine 10
34
23þ 11 5
Quinine 10
34
12þ 11 4
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block the K

conductance in ZG [1], also inhibited
[
3
H]glibenclamide binding in ZGM. The K
ATP
channel open-
ers, minoxidil sulfate and diazoxide, had only a small inhib-
itory e¡ect on [
3
H]glibenclamide binding at the concentrations
tested (Table 1).
3.3. Photoa¤nity labeling
As glibenclamide is photoactivatable and can be linked to
its receptors by UV irradiation [19], photoa¤nity labeling ex-
periments were performed for identi¢cation of the glibencla-
mide-binding protein in ZGM. In preliminary experiments,
the e¡ects of di¡erent wavelengths, irradiation times and
[
3
H]glibenclamide and protein concentrations were examined
(data not shown). By an optimized protocol as described
under Section 2, a peak of covalently bound radioactivity
that could be displaced by unlabeled glibenclamide was ob-
tained at 65þ 1.5 kDa (meansþS.E.M.; n=4; Fig. 3). This
corresponds to the molecular weight of a V65 kDa mdr1
gene product that is supposed to regulate K

and Cl
3
con-
ductances in ZG [10,11].
4. Discussion
In this study, we could show that glibenclamide inhibits the
K

selective cation conductance of ZG completely in a dose-
dependent manner. The inhibition of the Na

-permeable cat-
ion conductance was partial and independent of the concen-
tration of glibenclamide tested, suggesting a non-speci¢c ef-
fect. Based on these results, we investigated the binding
properties of ZGM for [
3
H]glibenclamide. Using a rapid ¢l-
tration assay, we found a single class of low-a¤nity binding
sites with a K
d
of 5.6 þ 1.1 WM, which in photolabeling experi-
ments could be shown to be associated with a 65 kDa protein.
The main di¡erences between the glibenclamide binding site
of ZGM and SUR 1 are the 10
3
^10
4
-fold higher a¤nity of
SUR 1 for [
3
H]glibenclamide binding as compared to the
ZGM binding site and the di¡erent molecular weights (SUR
1 has a predicted molecular weight of 177 kDa) [5]. Further-
more, there are di¡erences with respect to their pharmacolog-
ical pro¢les. The rank of potencies of second-generation sul-
fonylureas for [
3
H]glibenclamide binding inhibition is
glibenclamide s glipizide s gliquidone s glisoxepide s gli-
clacide for the high-a¤nity site of pancreatic L-cells [23], while
in ZGM the sequence is glibenclamide= gliquidones glipizi-
des glisoxepides gliclacide. Moreover, ATP requires Mg
2
for inhibiting [
3
H]glibenclamide binding to the pancreatic
L-cell high-a¤nity site, and it cannot be replaced by non-hy-
drolysable ATP analogues [24]. In ZGM, the inhibitory e¡ect
of ATP on [
3
H]glibenclamide binding was independent of
Mg
2
, and also non-hydrolysable ATP analogues were inhib-
itory.
Apart from the high-a¤nity sites probably representing
SUR 1, in several tissues, such as pancreatic L-cells, smooth
muscle and brain, low-a¤nity glibenclamide binding sites
have been described (K
d
between 2 nM and 16 WM; for re-
view, see [25]). Some of these sites may represent SUR 2, an
isoform of SUR 1 that has recently been cloned [6]. SUR 2
has a predicted molecular weight of 174 kDa and is assumed
to couple to Kir 6.2 to form the cardiac K
ATP
channel. A
detailed pharmacological pro¢le of SUR has not been pub-
lished. In addition, recently a mitochondrial low-a¤nity gli-
benclamide binding site has been associated with a 28 kDa
polypeptide, which has been postulated to represent the mito-
chondrial SUR [26].
Another member of the ABC-transporter superfamily,
CFTR, has also been associated with the regulation of K

channel activity: CFTR coexpression with Kir 1.1b
(ROMK2) enhances the glibenclamide sensitivity of Kir 1.1b
[27].
Previously, we have shown that a V65 kDa mdr1-gene
product is involved in the regulation of K

and Cl
3
conduct-
ances in ZG [10,11]. This corresponds to the molecular weight
of the glibenclamide binding protein in ZGM as determined
by photoa¤nity labeling experiments. In combination with a
recent preliminary report describing the presence of a Kir
channel protein in ZGM [28], our data indicate that the
ATP-sensitive K

channel of ZGM, similar to the K
ATP
chan-
nel of pancreatic L-cells, may be composed of several subu-
nits, including an ABC transporter.
There are precedents for the intracellular location of gliben-
clamide binding proteins: more than 90% of the high-a¤nity
glibenclamide binding sites of pancreatic L-cells have been
shown to be located intracellularly, in particular also in asso-
ciation with insulin secretory granules [29,30]. The functional
signi¢cance of this ¢nding is unclear, but it has been specu-
lated that SURs in secretory granules are involved in plasma-
membrane voltage-independent insulin secretion induced by
sulfonylureas [31]. Another example is the above-mentioned
low-a¤nity glibenclamide binding site in mitochondria [26].
What is the physiological role of the ATP-sensitive K

channel of ZGM? Agonist-induced enzyme secretion in per-
meabilized pancreatic acinar cells depends on the presence of
both cytosolic K

and Cl
3
[32]. The K

conductance of ZG is
assumed to be involved in exocytosis of the zymogen granule
content after fusion with the plasma membrane through active
secretion of K

and H
2
O into the intragranular space, possi-
bly serving `£ushing out' of macromolecular digestive enzymes
[1]. However, the signaling pathways and the mechanisms of
activation of K

conductance during secretagogue-induced
enzyme and £uid secretion remain to be fully elucidated.
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Fig. 3. Photoa¤nity labeling of ZGM with [
3
H]glibenclamide. One
out of 4 similar experiments is shown. The experiment was per-
formed as described under Section 2 (x-axis, position of the gel
slice; y-axis, radioactivity in cpm eluted from the gel slice; top, po-
sitions of the molecular weight markers).
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